887 related articles for article (PubMed ID: 33358970)
1. Continuous subcutaneous insulin infusion does not correspond with pregnancy outcomes despite better glycemic control as compared to multiple daily injections in type 1 diabetes - Significance of pregnancy planning and prepregnancy HbA1c.
Żurawska-Kliś M; Kosiński M; Kuchnicka A; Rurka M; Hałucha J; Wójcik M; Cypryk K
Diabetes Res Clin Pract; 2021 Feb; 172():108628. PubMed ID: 33358970
[TBL] [Abstract][Full Text] [Related]
2. Continuous subcutaneous insulin infusion versus multiple daily injection therapy in pregnant women with type 1 diabetes.
Gong Y; Wei T; Liu Y; Wang J; Yan J; Yang D; Luo S; Weng J; Zheng X
J Diabetes; 2024 May; 16(5):e13558. PubMed ID: 38664886
[TBL] [Abstract][Full Text] [Related]
3. Glycemic control and selected pregnancy outcomes in type 1 diabetes women on continuous subcutaneous insulin infusion and multiple daily injections: the significance of pregnancy planning.
Cyganek K; Hebda-Szydlo A; Katra B; Skupien J; Klupa T; Janas I; Kaim I; Sieradzki J; Reron A; Malecki MT
Diabetes Technol Ther; 2010 Jan; 12(1):41-7. PubMed ID: 20082584
[TBL] [Abstract][Full Text] [Related]
4. Higher rates of large-for-gestational-age newborns mediated by excess maternal weight gain in pregnancies with Type 1 diabetes and use of continuous subcutaneous insulin infusion vs multiple dose insulin injection.
Hauffe F; Schaefer-Graf UM; Fauzan R; Schohe AL; Scholle D; Sedlacek L; Scherer KA; Klapp C; Ramsauer B; Henrich W; Schlembach D; Abou-Dakn M
Diabet Med; 2019 Feb; 36(2):158-166. PubMed ID: 30698863
[TBL] [Abstract][Full Text] [Related]
5. Pregnancy Outcomes and Insulin Requirements in Women with Type 1 Diabetes Treated with Continuous Subcutaneous Insulin Infusion and Multiple Daily Injections: Cohort Study.
Abell SK; Suen M; Pease A; Boyle JA; Soldatos G; Regan J; Wallace EM; Teede HJ
Diabetes Technol Ther; 2017 May; 19(5):280-287. PubMed ID: 28282241
[TBL] [Abstract][Full Text] [Related]
6. Continuous Subcutaneous Insulin Infusion During Pregnancy in Women with Complicated Type 1 Diabetes Is Associated with Better Glycemic Control but Not with Improvement in Pregnancy Outcomes.
Kekäläinen P; Juuti M; Walle T; Laatikainen T
Diabetes Technol Ther; 2016 Mar; 18(3):144-50. PubMed ID: 26502287
[TBL] [Abstract][Full Text] [Related]
7. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes.
Farrar D; Tuffnell DJ; West J; West HM
Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD005542. PubMed ID: 27272351
[TBL] [Abstract][Full Text] [Related]
8. Glycemic control and perinatal outcomes of pregnancies complicated by type 1 diabetes: influence of continuous subcutaneous insulin infusion and lispro insulin.
Chico A; Saigi I; García-Patterson A; Santos MD; Adelantado JM; Ginovart G; de Leiva A; Corcoy R
Diabetes Technol Ther; 2010 Dec; 12(12):937-45. PubMed ID: 21128840
[TBL] [Abstract][Full Text] [Related]
9. Continuous subcutaneous insulin infusion reduces neonatal risk in pregnant women with type 1 diabetes mellitus.
Mantaj U; Gutaj P; Ozegowska K; Zawiejska A; Wroblewska-Seniuk K; Olejniczak D; Wender-Ozegowska E
Ginekol Pol; 2019; 90(3):154-160. PubMed ID: 30950005
[TBL] [Abstract][Full Text] [Related]
10. Continuous Subcutaneous Infusion Versus Multiple Daily Injections of Insulin for Pregestational Diabetes in Pregnancy: A Systematic Review and Meta-Analysis.
Fisher SA; Huang J; DuBord AY; Xu NY; Beestrum M; Niznik C; Yeung AM; Nguyen KT; Klonoff DC; Yee LM
J Diabetes Sci Technol; 2023 Sep; 17(5):1337-1363. PubMed ID: 37542367
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy outcome and glycemic control in women with type 1 diabetes: a retrospective comparison between CSII and MDI treatment.
Talaviya PA; Saboo BD; Joshi SR; Padhiyar JN; Chandarana HK; Shah SJ; Vyas CK; Shah AN
Diabetes Metab Syndr; 2013; 7(2):68-71. PubMed ID: 23680243
[TBL] [Abstract][Full Text] [Related]
12. Maternal-fetal outcomes of pregnant women with type 1 diabetes treated with continuous subcutaneous insulin infusion or multiple daily injections during pregnancy - A Brazilian health care referral center cohort study.
Ogassavara J; Dualib PM; Mattar R; Dib SA; de Almeida-Pititto B
Arch Endocrinol Metab; 2023 Jun; 67(6):e220483. PubMed ID: 37364140
[TBL] [Abstract][Full Text] [Related]
13. Continuous glucose monitoring and insulin pump therapy in pregnant women with type 1 diabetes mellitus.
Lason I; Cyganek K; Witek P; Matejko B; Malecki MT; Skupien J
Ginekol Pol; 2021; 92(10):675-681. PubMed ID: 33914316
[TBL] [Abstract][Full Text] [Related]
14. Advances in diabetes management: have pregnancy outcomes in women with type 1 diabetes changed in the last decades?
Citro F; Bianchi C; Nicolì F; Aragona M; Marchetti P; Di Cianni G; Bertolotto A
Diabetes Res Clin Pract; 2023 Nov; 205():110979. PubMed ID: 37890701
[TBL] [Abstract][Full Text] [Related]
15. Pre-pregnancy care and pregnancy outcomes in type 1 diabetes mellitus: a comparison of continuous subcutaneous insulin infusion and multiple daily injection therapy.
Neff KJ; Forde R; Gavin C; Byrne MM; Firth RG; Daly S; McAuliffe FM; Foley M; Coffey M; Coulter-Smith S; Kinsley BT
Ir J Med Sci; 2014 Sep; 183(3):397-403. PubMed ID: 24142539
[TBL] [Abstract][Full Text] [Related]
16. Insulin Delivery Method and Admission for Glycemic Control in Pregnant Women with Type 1 Diabetes Mellitus.
Sperling JD; Maggio L; Has P; Daley J; Coustan DR; Werner EF
Am J Perinatol; 2018 Feb; 35(3):209-214. PubMed ID: 28709165
[TBL] [Abstract][Full Text] [Related]
17. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
[TBL] [Abstract][Full Text] [Related]
18. Continuous subcutaneous insulin infusion vs multiple daily injections in pregnant women with type 1 diabetes mellitus: a systematic review and meta-analysis of randomised controlled trials and observational studies.
Rys PM; Ludwig-Slomczynska AH; Cyganek K; Malecki MT
Eur J Endocrinol; 2018 May; 178(5):545-563. PubMed ID: 29545258
[TBL] [Abstract][Full Text] [Related]
19. Type 1 diabetes control and pregnancy outcomes in women treated with continuous subcutaneous insulin infusion (CSII) or with insulin glargine and multiple daily injections of rapid-acting insulin analogues (glargine-MDI).
Bruttomesso D; Bonomo M; Costa S; Dal Pos M; Di Cianni G; Pellicano F; Vitacolonna E; Dodesini AR; Tonutti L; Lapolla A; Di Benedetto A; Torlone E;
Diabetes Metab; 2011 Nov; 37(5):426-31. PubMed ID: 21474360
[TBL] [Abstract][Full Text] [Related]
20. Use of continuous subcutaneous insulin infusion versus multiple daily injections in emerging adults with type 1 diabetes is associated with better clinical engagement but not glycaemic control.
Chai TYL; Farrell K; Holmes-Walker DJ
Intern Med J; 2023 Feb; 53(2):255-261. PubMed ID: 34561942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
